首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-咪唑-5-基)甲基)-53-氨基-14,23,26,44-四(4-氨基丁基)-8,20,41-三苄基-50-((S)-仲丁基)-32-(羟甲基)-38-异丁基-5-异丙基-11,29-二甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-十七氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十七氮杂五十三烷酰胺基)-5-(2-氨基-2-氧代乙基)-11-((S)-仲丁基)-2-(羟甲基)-8-(2-(甲硫基)乙基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十七烷二酸

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-咪唑-5-基)甲基)-53-氨基-14,23,26,44-四(4-氨基丁基)-8,20,41-三苄基-50-((S)-仲丁基)-32-(羟甲基)-38-异丁基-5-异丙基-11,29-二甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-十七氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十七氮杂五十三烷酰胺基)-5-(2-氨基-2-氧代乙基)-11-((S)-仲丁基)-2-(羟甲基)-8-(2-(甲硫基)乙基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十七烷二酸

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-imidazol-5-yl)methyl)-53-amino-14,23,26,44-tetrakis(4-aminobutyl)-8,20,41-tribenzyl-50-((S)-sec-butyl)-32-(hydroxymethyl)-38-isobutyl-5-isopropyl-11,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-heptadecaazatripentacontanamido)-5-(2-amino-2-oxoethyl)-11-((S)-sec-butyl)-2-(hydroxymethyl)-8-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

108433-95-0

中文名称

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-咪唑-5-基)甲基)-53-氨基-14,23,26,44-四(4-氨基丁基)-8,20,41-三苄基-50-((S)-仲丁基)-32-(羟甲基)-38-异丁基-5-异丙基-11,29-二甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-十七氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十七氮杂五十三烷酰胺基)-5-(2-氨基-2-氧代乙基)-11-((S)-仲丁基)-2-(羟甲基)-8-(2-(甲硫基)乙基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十七烷二酸

英文名称

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-imidazol-5-yl)methyl)-53-amino-14,23,26,44-tetrakis(4-aminobutyl)-8,20,41-tribenzyl-50-((S)-sec-butyl)-32-(hydroxymethyl)-38-isobutyl-5-isopropyl-11,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-heptadecaazatripentacontanamido)-5-(2-amino-2-oxoethyl)-11-((S)-sec-butyl)-2-(hydroxymethyl)-8-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid

别名

Z-12 Peptide | Magainin-2, Xenopus | NH2-Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Asn-Ser-COOH | Magainin II, Xenopus | magainin 2 peptide, Xenopus | AKOS040764010 | Mag-2 | Magainin 2, Xenopus | Magainin-2 | Mag

标准英文名

(2S,5S,8S,11S,14S)-14-((5S,8S,11S,14S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S)-35-((1H-imidazol-5-yl)methyl)-53-amino-14,23,26,44-tetrakis(4-aminobutyl)-8,20,41-tribenzyl-50-((S)-sec-butyl)-32-(hydroxymethyl)-38-isobutyl-5-isopropyl-11,29-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-heptadecaazatripentacontanamido)-5-(2-amino-2-oxoethyl)-11-((S)-sec-butyl)-2-(hydroxymethyl)-8-(2-(methylthio)ethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid

MDL No.

MFCD00133522

分子式

C114H180N30O29S

分子量

2466.94

精确分子量

2465.33

SMILES

CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C

标准SMILES

CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O

用途

Magainin 2 (Magainin II) is an antimicrobial peptide (AMP) isolated from the skin of the African clawed frog (Xenopus laevis). It exhibits broad-spectrum antibiotic activity against both Gram-negative and Gram-positive bacteria, as well as antiprotozoal activity. Magainin 2 exerts its cytotoxic effects primarily by interacting with anionic phospholipids abundant in bacterial membranes, leading to membrane permeabilization without significant toxicity to mammalian cells. It induces bactericidal effects and morphological changes associated with early apoptosis in Escherichia coli. Magainin 2 also triggers the expression of a bacterial protein with affinity for caspase substrates and modulates the expression of RecA as a caspase-like protein. Application of Magainin 2 (e.g., at 10 μg/mL) to the protozoan Paramecium caudatum causes osmotic swelling and subsequent cell lysis, indicating disruption of membrane functions critical for osmotic balance. The peptide forms pores (~2.8 nm in diameter) in bacterial membranes (e.g., Bacillus megaterium), enabling translocation into the cytosol, while in mammalian cells (e.g., CHO-K1), it induces distinct membrane perturbations—such as membrane budding, lipid flip-flop, and entry of large molecules (>23 nm)—with intracellular accumulation primarily in mitochondria and nuclei.

InChIKey

MGIUUAHJVPPFEV-ABXDCCGRSA-N

安全信息

SureRoute逆合成路线

1.  108433-95-0 逆合成路线 1

—
—
ACRMPQ740
108433-95-0
来源: SureRoute

2.  108433-95-0 逆合成路线 2

—
—
ACRMPQ740
108433-95-0
来源: SureRoute

3.  108433-95-0 逆合成路线 3

—
—
ACRMPQ740
108433-95-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手